Synthetic Human Secretin in Children With Autism and Gastrointestinal Dysfunction
Phase 3
Terminated
- Conditions
- Autism
- Registration Number
- NCT00036231
- Lead Sponsor
- Repligen Corporation
- Brief Summary
The purpose of the study is to determine the effect of multiple doses of secretin on autism.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method